kzr-616
Showing 1 - 4 of 4
Polymyositis, Dermatomyositis Trial in Worldwide (KZR-616, Placebo)
Completed
- Polymyositis
- Dermatomyositis
- KZR-616
- Placebo
-
Beverly Hills, California
- +18 more
Sep 30, 2022
Polymyositis, Dermatomyositis Trial in United States (KZR-616)
Enrolling by invitation
- Polymyositis
- Dermatomyositis
- KZR-616
-
Beverly Hills, California
- +6 more
Nov 26, 2021
Lupus Nephritis, Systemic Lupus Erythematosus Trial in Worldwide (KZR-616)
Active, not recruiting
- Lupus Nephritis
- Systemic Lupus Erythematosus
- KZR-616
-
Los Angeles, California
- +49 more
Mar 10, 2022
Autoimmune Hemolytic Anemia, Immune Thrombocytopenia Trial in Worldwide (KZR-616)
Withdrawn
- Autoimmune Hemolytic Anemia
- Immune Thrombocytopenia
- KZR-616
-
Los Angeles, California
- +21 more
Aug 5, 2020